Clinical trial
Fenofibrate Combined With Ursodeoxycholic Acid in Compensated Cirrhosis Patients With Primary Biliary Cholangitis Who Had an Inadequate Response to Ursodeoxycholic Acid
NCT05749822 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fenofibrate Combined With Ursodeoxycholic Acid in Compensated Cirrhosis Patients With Primary Biliary Cholangitis Who Had an Inadequate Response to Ursodeoxycholic Acid
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- February 17, 2023
- Completion date
- December 31, 2027
- Enrollment
- 104 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
primary biliary cholangitis